➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Dow
Colorcon
Boehringer Ingelheim
Moodys

Last Updated: April 22, 2021

DrugPatentWatch Database Preview

BROMOCRIPTINE MESYLATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Bromocriptine Mesylate, and when can generic versions of Bromocriptine Mesylate launch?

Bromocriptine Mesylate is a drug marketed by Lek Pharm, Mylan, Zydus Pharms Usa Inc, Paddock Llc, and Sandoz Inc. and is included in six NDAs.

The generic ingredient in BROMOCRIPTINE MESYLATE is bromocriptine mesylate. There are nine drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the bromocriptine mesylate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Bromocriptine Mesylate

A generic version of BROMOCRIPTINE MESYLATE was approved as bromocriptine mesylate by SANDOZ INC on January 13th, 1998.

  Get Started Free

Drug patent expirations by year for BROMOCRIPTINE MESYLATE
Drug Prices for BROMOCRIPTINE MESYLATE

See drug prices for BROMOCRIPTINE MESYLATE

Recent Clinical Trials for BROMOCRIPTINE MESYLATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
VeroSciencePhase 1
Mylan PharmaceuticalsPhase 1
VeroSciencePhase 3

See all BROMOCRIPTINE MESYLATE clinical trials

Pharmacology for BROMOCRIPTINE MESYLATE
Medical Subject Heading (MeSH) Categories for BROMOCRIPTINE MESYLATE

US Patents and Regulatory Information for BROMOCRIPTINE MESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lek Pharm BROMOCRIPTINE MESYLATE bromocriptine mesylate CAPSULE;ORAL 075100-001 Dec 10, 1998 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Mylan BROMOCRIPTINE MESYLATE bromocriptine mesylate TABLET;ORAL 076962-001 Sep 24, 2004 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Mylan BROMOCRIPTINE MESYLATE bromocriptine mesylate CAPSULE;ORAL 077226-001 Apr 4, 2005 AB RX No Yes   Get Started Free   Get Started Free   Get Started Free
Zydus Pharms Usa Inc BROMOCRIPTINE MESYLATE bromocriptine mesylate CAPSULE;ORAL 078899-001 Jul 30, 2008 AB RX No No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
McKesson
Express Scripts
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.